Clonal isolation of Borrelia miyamotoi identifies multiple infection phenotypes and potential novel virulence determinants
Microbiology Spectrum · 03.11.2026 · 14 (11)
DOI: 10.1128/spectrum.01526-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Dawn Cleveland und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA. Hauptthemen laut MEDLINE: Borrelia, Relapsing Fever, Virulence Factors, Borrelia Infections. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Borrelia miyamotoi is an emerging tick-borne pathogen in the Northern Hemisphere that causes a relapsing fever-like illness known as Borrelia miyamotoi disease. Despite increased recognition of B. miyamotoi as a human pathogen, the mechanisms underlying infection and pathology remain poorly understood. During routine cultivation of B. miyamotoi LB-2001, our lab observed that bacterial cultures extensively passaged in vitro (over 70 passages) lost the ability to establish infection in severe combined immunodeficiency (SCID) mice. Clonal populations were isolated from both high- and low-passage cultures, and three distinct phenotypes were emerged—infections, attenuated, and non-infectious—each showing an inverse correlation between culture growth and infectivity in SCID mice. Infection outcomes in mice revealed differences in spirochetemia, hepatosplenomegaly, and anemia among the clones. Genomic DNA sequencing identified potential virulence determinants associated with these infectious phenotypes. These findings lay the groundwork for uncovering molecular mechanisms of B. miyamotoi pathogenesis and identifying targets to mitigate the impact of this emerging pathogen. IMPORTANCE As global expansion of tick habitats increases, tick-borne diseases are becoming more prevalent and widespread. The emerging tick-borne pathogen Borrelia miyamotoi warrants increased scrutiny. This work demonstrates loss of infectivity in immunocompromised mice by B. miyamotoi subjected to continual in vitro cultivation, as well as the isolation of clonal populations that demonstrate differences in infectivity with three distinct phenotypes: infectious, attenuated, and non-infectious. Characterizing how clonal isolates have differences in infectivity can lead to the identification of novel factors required for virulence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
- Department of Microbiology and Immunology, University of Southern Alabama, Mobile, Alabama, USA.
- Department of Biology, University of North Dakota, Grand Forks, North Dakota, USA.
- North Dakota Veterinary Diagnostic Laboratory, North Dakota State University, Fargo, North Dakota, USA.
ORCID-Profile: Heidi Pecoraro, Catherine A Brissette
Zitieren
APA
Cleveland, D., Tourand, Y., Casselli, T., Long, T., Nguyen, H., Aldinger, A., Pecoraro, H., & Brissette, C. A. (2026). Clonal isolation of Borrelia miyamotoi identifies multiple infection phenotypes and potential novel virulence determinants. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.01526-26
Vancouver
Cleveland D, Tourand Y, Casselli T, Long T, Nguyen H, Aldinger A, et al. Clonal isolation of Borrelia miyamotoi identifies multiple infection phenotypes and potential novel virulence determinants. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.01526-26
BibTeX
@article{Cleveland2026,
author = {Cleveland, Dawn and Tourand, Yvonne and Casselli, Timothy and Long, Trevor and Nguyen, Hoa and Aldinger, Amy and Pecoraro, Heidi and Brissette, Catherine A},
title = {Clonal isolation of Borrelia miyamotoi identifies multiple infection phenotypes and potential novel virulence determinants},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {11},
doi = {10.1128/spectrum.01526-26}
}
EUVIMED